chemXplore tracks 66 projects in Finland, of which 30 are active.
Of the active ones, 25 new construction, 2 expansion, 2 revamp / retrofit and 1 conversion / repurposing.
3 active projects carry no start-up date yet. The dates themselves, per project, are for subscribers.
The recommendation covers people vaccinated at least two years earlier; EU authorisation is still pending.
Cost-savings programme delivered substantial profit improvement early in Q4; sales and operating results declined year-on-year; investments in fibre packaging and a CO2 capture project announced.
Revenue rose to SEK 30.4bn and operating profit to SEK 5.4bn (SEK 4.9bn excl. PIR). Stable production; records at Kevitsa and Harjavalta; agreement to buy 64.68% of Nexa Resources.
Record renewables margins and volumes, wide middle‑distillate margins, reduced leverage and an expanded Rotterdam capex estimate to ~€3.0bn with start‑up by end‑2027.
Q3 sales €2,202m and comparable EBIT €131m; operating cash flow rose to €420m as working‑capital measures offset lower deliveries and higher variable costs.
Plywood business to list on Nasdaq Helsinki with trading expected in early November; existing shareholders receive one new listed share per current share.
EU clears first PD‑1 inhibitor plus ADC regimen for resectable muscle‑invasive bladder cancer regardless of cisplatin eligibility; phase 3 showed EFS HR 0.53 and OS HR 0.65.
China’s regulator approved a plant-based, water‑soluble CMC excipient for pharmaceutical manufacturing, enabling supply into China’s large drug production market.
200–300 MW Kotka plant will make power from natural gas without CO2 by splitting methane into hydrogen and solid carbon for combustion and industrial use.
€1bn Europe-wide auction for industrial process-heat decarbonisation; bidding opens early Dec 2026. Supports electrification, renewable heat and SMRs with a fixed premium per tCO2.
active / all projects